|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-1mL
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116055-1mg
|
MedChemexpress LLC
|
(2R)-Glycerol-O-Beta-D-galactopyranoside [CAS 16232-91-0]
|
|
|
|
|
HY-137440B-1mg
|
MedChemexpress LLC
|
(2R,3R)-Firazorexton [CAS 2692692-00-3]
|
|
|
|
|
HY-137440B-10mg
|
MedChemexpress LLC
|
(2R,3R)-Firazorexton [CAS 2692692-00-3]
|
|
|
|
|
HY-137440B-5mg
|
MedChemexpress LLC
|
(2R,3R)-Firazorexton [CAS 2692692-00-3]
|
|
|
|
|
HY-14664F-1mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14664F-10mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14664F-5mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
|
HY-Z0031-500mg
|
MedChemexpress LLC
|
(R)-(-)-1,2-Propanediol [CAS 4254-14-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-Z0031-1mL
|
MedChemexpress LLC
|
(R)-(-)-1,2-Propanediol [CAS 4254-14-2] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-12515C-10mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-100mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-25mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-5mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-50mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N6937-10mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-20mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-5mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-1mL
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-W127363-250mg
|
MedChemexpress LLC
|
(Rac)-1,2-Dihexadecylglycerol [CAS 13071-60-8]
|
|
|
|
|
HY-66011B-1mg
|
MedChemexpress LLC
|
(Rac)-Moxifloxacin [CAS 354812-41-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-120973A-500ug
|
MedChemexpress LLC
|
(S)-Butaprost (free acid) [CAS 433219-55-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
